Cover Image
市場調查報告書

次世代定序 (NGS) 服務的歐洲市場預測 ∼2020年:各技術 (SBS、SBL、SMRT、焦磷酸定序)、用途、終端用戶、疾病

European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

出版商 MarketsandMarkets 商品編碼 342074
出版日期 內容資訊 英文 213 Pages
訂單完成後即時交付
價格
Back to Top
次世代定序 (NGS) 服務的歐洲市場預測 ∼2020年:各技術 (SBS、SBL、SMRT、焦磷酸定序)、用途、終端用戶、疾病 European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
出版日期: 2015年10月13日 內容資訊: 英文 213 Pages
簡介

歐洲的次世代定序 (NGS) 服務的市場預計從2015年到2020年以21%的年複合成長率發展,從2015年的4億4400萬美元,成長到2020年的11億5200萬美元的規模。這個成長主要由於速度與成本效率、與其他的平台比較的NGS的熱門、遺傳性疾病的發病率擴大、基因學的藥物研發的應用、癌症、其他惡性疾病的發病率 擴大,在企業、研發中心、大學間的聯盟等要素而推動。

本報告提供歐洲的次世代定序 (NGS) 服務的市場相關調查、主要的技術與用途定義、市場及技術的發展過程、主要的法律規章與認證、客戶的認識的相關調查、市場成長的各種影響因素分析、各技術/用途/疾病區隔/終端用戶/主要國家趨勢與市場規模的變化與預測、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場發展的過程
  • 市場區隔
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第5章 產業趨勢

  • 價格分析
  • 投資者分析
  • 大環境分析

第6章 法律規章、認證相關環境

第7章 客戶的認識相關分析

第8章 基準參數、未來趨勢

第9章 市場分析:各技術

  • SBS
  • 離子半導體
  • SBL
  • 焦磷酸定序
  • SMRT

第10章 市場分析:各用途

  • 用途 (I)
    • 研究
    • 臨床
  • 用途 (II)
    • RNA定序
    • 目標定序
    • EXOME定序
    • 全基因定序
    • CHIP定序
    • 甲基化定序
    • 從頭定序
    • 其他

第11章 市場分析:各疾病種類

  • 概要
  • 癌症
    • 肺癌
    • 乳癌
    • 前列腺癌
    • 大腸癌
    • 其他

第12章 市場分析:各終端用戶

  • 研究中心、學術機構、政府機關
  • 醫院、診療所
  • 醫藥品、生物科技企業
  • 其他

第13章 地區分析

  • 簡介
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 其他

第14章 競爭環境

  • 新產品的投入
  • 政府的資金供給
  • 市場佔有率分析

第15章 企業簡介

  • BEIJING GENOMICS INSTITUTE (BGI)
  • CEGAT (CENTRE FOR GENOMICS AND TRANSCRIPTOMICS) GMBH
  • DNA VISION SA
  • EUROFINS GENOMICS INC.
  • FEBIT / COMPREHENSIVE BIOMARKER CENTER GMBH (CBC)
  • GENOMNIA SRL
  • ILLUMINA INC.
  • MACROGEN INC.
  • MICROSYNTH AG
  • SEQOMICS
  • SOURCE BIO SCIENCE

第16章 附錄

圖表

目錄
Product Code: BT 3781

The NGS services market in Europe is expected to reach USD 1,152 million by 2020 from USD 444 million in 2015, at a CAGR of 21% from 2015 to 2020. The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country.

The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference of NGS over other platforms; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities. Technological advancements have widened the scope of NGS as they assist in the detection of various tumors, malignancies, and other oncological conditions in the early stages. Cancer genomes are extremely complex and diverse; NGS is used to detect mutations and perform many tests at once in such heterogeneous samples; thus playing an important role in cancer research.

Apart from comprehensive technology, application, end-user, and country-level analysis and market sizing, the report also provides the company profiles which comprise basic views on key players with regard to business overview, service offerings, and developments in this market. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding service offerings, regional focus, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, new services/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Information on the service portfolios of the key players in the European NGS services market. The report analyzes this market by technology, application, end user, disease type, and region
  • NGS Services/Innovations: Insights on R&D activities and new service launches in the European NGS services market
  • Competitive Assessment: In-depth assessment of geographical & business segments and service portfolios of some of the key players in the European NGS services market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various NGS technologies and applications across regions
  • Market Diversification: Information about new services, recent developments, and investments in the European NGS services marke

Table of Contents

1. INTRODUCTION

  • 1.1. OBJECTIVES
  • 1.2. MARKET DEFINITIONS
  • 1.3. MARKET SCOPE

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. EVOLUTION
  • 4.3. MARKET SEGMENTATION
  • 4.4. MARKET DYNAMICS
    • 4.4.1. DRIVERS
    • 4.4.2. RESTRAINTS
    • 4.4.3. OPPORTUNITIES
    • 4.4.4. CHALLENGES

5. INDUSTRY INSIGHTS

  • 5.1. PRICING ANALYSIS
  • 5.2. INVESTOR ANALYSIS
  • 5.3. PESTEL ANALYSIS

6. REGULATION AND CERTIFICATION LANDSCAPE

7. CUSTOMER PERCEPTION ANALYSIS

8. BENCHMARK PARAMETERS AND FUTURISTIC TRENDS

9. EUROPEAN NGS SERVICES MARKET, BY TECHNOLOGY

  • 9.1. SBS
  • 9.2. ION SEMICONDUCTOR
  • 9.3. SBL
  • 9.4. PYRO-SEQUENCING
  • 9.5. SMRT

10. EUROPEAN NGS SERVICES MARKET, BY APPLICATION

  • 10.1. APPLICATION (I)
    • 10.1.1. RESEARCH APPLICATIONS
    • 10.1.2. CLINICAL APPLICATIONS
  • 10.2. APPLICATION (II)
    • 10.2.1. RNA-SEQUENCING
    • 10.2.2. TARGETED SEQUENCING
    • 10.2.3. EXOME SEQUENCING
    • 10.2.4. WHOLE GENOME SEQUENCING
    • 10.2.5. CHIP-SEQUENCING
    • 10.2.6. METHYL-SEQUENCING
    • 10.2.7. DE NOVO SEQUENCING
    • 10.2.8. OTHERS

11. EUROPEAN NGS SERVICES MARKET, BY DISEASE TYPE

  • 11.1. OVERVIEW
  • 11.2. ONCOLOGY
    • 11.2.1. LUNG CANCER
    • 11.2.2. BREAST CANCER
    • 11.2.3. PROSTATE CANCER
    • 11.2.4. COLORECTAL CANCER
    • 11.2.5. OTHERS

12. EUROPEAN NGS SERVICES MARKET, BY END USER

  • 12.1. RESEARCH CENTERS, ACADEMIC & GOVERNMENT INSTITUTES
  • 12.2. HOSPITALS & CLINICS
  • 12.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 12.4. OTHERS

13. EUROPEAN NGS SERVICES MARKET, BY GEOGRAPHY

  • 13.1. INTRODUCTION
  • 13.2. U.K.
  • 13.3. GERMANY
  • 13.4. FRANCE
  • 13.5. ITALY
  • 13.6. SPAIN
  • 13.7. NETHERLANDS
  • 13.8. REST OF THE EUROPE (ROE)

14. COMPETITIVE LANDSCAPE

  • 14.1. NEW PRODUCT LAUNCHES
  • 14.2. GOVERNMENT FUNDING
  • 14.3. MARKET SHARE ANALYSIS

15. COMPANY PROFILES

  • 15.1. BEIJING GENOMICS INSTITUTE (BGI)
  • 15.2. CEGAT (CENTRE FOR GENOMICS AND TRANSCRIPTOMICS) GMBH
  • 15.3. DNA VISION SA
  • 15.4. EUROFINS GENOMICS INC.
  • 15.5. FEBIT / COMPREHENSIVE BIOMARKER CENTER GMBH (CBC)
  • 15.6. GENOMNIA SRL
  • 15.7. ILLUMINA INC.
  • 15.8. MACROGEN INC.
  • 15.9. MICROSYNTH AG
  • 15.1. SEQOMICS
  • 15.11. SOURCE BIO SCIENCE

16. APPENDIX

  • 16.1. CERTIFIED NGS SERVICE PROVIDERS IN EUROPE
  • 16.2. MAJOR END USERS OF NGS SERVICES
  • 16.3. RELATED REPORTS

List of Tables

  • TABLE 1: EUROPEAN NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 2: SBS TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 3: ION SEMICONDUCTOR TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 4: SBL TECHNOLOGY-BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 5: PYROSEQUENCING TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 6: SMRT TECHNOLOGY BASED SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 7: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATION (I), 2013-2020 (USD MILLION)
  • TABLE 8: NGS SERVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 9: NGS SERVICES MARKET SIZE FOR CLINICAL APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATION (II), 2013-2020 (USD MILLION)
  • TABLE 11: RNA-SEQ SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: TARGETED SEQUENCING/GENE PANELS SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: EXOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 14: WHOLE GENOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: CHIP-SEQ SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: METHYL-SEQ SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: DE NOVO SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 18: OTHER SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: NGS SERVICES MARKET SIZE, BY DISEASE TYPE, 2013-2020 (USD MILLION)
  • TABLE 20: EUROPEAN NGS ONCOLOGY SERVICES MARKET, BY CANCER TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: NGS SERVICES MARKET SIZE FOR LUNG CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 22: NGS SERVICES MARKET SIZE FOR BREAST CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 23: NGS SERVICES MARKET SIZE FOR PROSTATE CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: NGS SERVICES MARKET SIZE FOR COLORECTAL CANCER, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 25: NGS SERVICES MARKET SIZE FOR OTHER ONCOLOGY DISEASES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: EUROPEAN NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 27: NGS SERVICES MARKET SIZE FOR RESEARCH CENTERS, ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: NGS SERVICES MARKET SIZE FOR HOSPITALS & CLINICS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: NGS SERVICES MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: NGS SERVICES MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 31: EUROPEAN NGS SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: EUROPEAN ONCOLOGY NGS SERVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: U.K.: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 34: U.K.: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 35: U.K.: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 36: U.K.: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 37: U.K.: NGS ONCOLOGY SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: GERMANY: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 39: GERMANY: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 40: GERMANY: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 41: GERMANY: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 42: GERMANY: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 43: FRANCE: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 44: FRANCE: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 45: FRANCE: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 46: FRANCE: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 47: FRANCE: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 48: ITALY: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 49: ITALY: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 50: ITALY: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 51: ITALY: NGS SERVICES MARKET SIZE, BY APPLICATIONS, (II) 2013-2020 (USD MILLION)
  • TABLE 52: ITALY: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: SPAIN: NGS SERVICES MARKET, BY TECHNOLOGY SIZE, 2013-2020 (USD MILLION)
  • TABLE 54: SPAIN: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 55: SPAIN: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 56: SPAIN: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II) 2013-2020 (USD MILLION)
  • TABLE 57: SPAIN: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 58: NETHERLANDS: NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 59: NETHERLANDS: NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2013-2020 (USD MILLION)
  • TABLE 60: NETHERLANDS: NGS SERVICES MARKET SIZE, BY END-USER, 2013-2020 (USD MILLION)
  • TABLE 61: NETHERLANDS: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 62: NETHERLANDS: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 63: ROE: NGS SERVICES MARKET, BY TECHNOLOGY SIZE, 2013-2020 (USD MILLION)
  • TABLE 64: ROE: NGS SERVICES MARKET SIZE, BY APPLICATIONS(I), 2013-2020 (USD MILLION)
  • TABLE 65: ROE: NGS SERVICES MARKET SIZE, BY END-USER , 2013-2020 (USD MILLION)
  • TABLE 66: ROE: NGS SERVICES MARKET SIZE, BY APPLICATIONS (II), 2013-2020 (USD MILLION)
  • TABLE 67: ROE: ONCOLOGY NGS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)

List of Figures

  • FIGURE 1: EUROPE NGS SERVICES MARKET SIZE, 2015-2020 (USD MILLION)
  • FIGURE 2: EUROPEAN NGS SERVICES: CUSTOMER SEGMENTATION, 2015
  • FIGURE 3: EUROPEAN NGS SERVICES: COUNTRY-WISE MARKET SHARE, 2015
  • FIGURE 4: EUROPEAN NGS SERVICES MARKET SIZE, 2014-2020 (USD MILLION)
  • FIGURE 5: PRICING ANALYSIS
  • FIGURE 6: EUROPEAN NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2015 & 2020 (USD MILLION)
  • FIGURE 7: EUROPEAN NGS SERVICES MARKET SIZE, BY TECHNOLOGY, 2011-2020 (USD MILLION)
  • FIGURE 8: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATIONS (I), 2015 & 2020 (USD MILLION)
  • FIGURE 9: EUROPEAN NGS SERVICES MARKET SIZE, BY APPLICATION (II), 2015 & 2020 (USD MILLION)
  • FIGURE 10: EUROPEAN NGS SERVICES MARKET SIZE, BY DISEASE TYPE, 2015 & 2020 (USD MILLION)
  • FIGURE 11: EUROPEAN NGS SERVICES MARKET SIZE, BY END USER, 2011-2020 (USD MILLION)
  • FIGURE 12: MARKET SHARE IN THE EUROPEAN NGS SERVICES MARKET (2014)
Back to Top